Recurrence of neuroleptic malignant syndrome with olanzapine treatment.

[1]  P. Buckley,et al.  Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique. , 1998, The American journal of psychiatry.

[2]  P. Perry,et al.  Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapy. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.